Instructions for Use
Personal Prophylactic Hygiene Care
Female Liquid Rectal Suppositories
Female Liquid rectal Suppositories SCHALI® Care–FI for treatment and prevention of sexually transmitted infections enable adjusting immune response. Besides, by blocking bonds necessary for internalization of virions and infection, active ingredients provide a strong beneficial effect by relieving symptoms of different pathological conditions, especially of microbial and viral contamination, caused by envelope-type viruses such as different strains of herpes (Herpesviridae).
Prophylactic hydrogel in 3 ml disposable single-dose container.
Aqua, Hydroxypropyl Cyclodextrin, Glycerin, Propylene Glycol, Glycereth-18 Ethylhexanoate, Glycereth-18, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Titanium Dioxide, Triethanolamine, Diazolidinyl Urea, Methylparaben, Propylparaben, Phosphoric Acid.
MECHANISM OF ACTION:
Soft hydrogel formulation of the suppositories dissolves slowly in the rectum, where it is absorbed by rectal mucosa. The product acts locally by inducing regeneration, strengthening vascular walls and improving microcirculation in capillaries.
Mineral bio-constituent of the hydrogel formulation includes fragments of a certain class of metalloid semiconductors with unsaturated bonds - titanium dioxide crystalline lattice - known for its high catalytic activity. Photoactive particles of QD SCHALI® titanium dioxide trigger generation of active oxygen forms (singlet oxygen). Mechanism of action is based on the principle of energetic neutralization of free chemical bonds on the surface of toxic compounds by saturating them with complementary oxygen atoms, generated in the result of the catalytic reaction. Active oxygen forms may successfully treat most of all currently known exogenous and endogenous intoxications.
Besides, active oxygen forms (singlet oxygen) trigger mechanism of activation in serotonin receptors, leading to better regulation of serotonin reuptake inhibition by selectively blocking serotonin absorption in presynaptic membrane. Re-balanced serotonin level helps in restoring homeostasis and ceasing thanatogenesis, promotes female health and function of cardiovascular system, improves cellular metabolism and condition of blood vessels, and induces immune response.
Regular use of the product contributes to better electrolyte and water metabolism in the cardiac muscle, creatine phosphate uptake, ATP transport to heart cells, and induces the cardiac muscle to increase its glycogen content. The product has a moderate cardiotonic effect, resulting in better regulation of contracting mechanism within the heart and better myocardial function. The product formulation enables better control over blood cholesterol by inhibiting both cholesterol build-up on artery walls and formation of atherosclerotic lesions. The product is beneficial to arterial tension as well.
The product is intended for personal care purposes, has preventive action and may be used as complex therapy and photodynamic therapy agents in treatment of a wide range of cardiovascular conditions for better myocardial function, better microcirculation and lower vascular penetrability, less swelling in vascular tissues and better vascular metabolism.
- Atherosclerosis conditions
- Myocarditis in connective tissue disease
- Cardiac ischemia
- Cardiac failure
- Arterial hypertension
METHOD OF USE:
For rectal use only.
Take one single-dose container out of the package with clean hands, insert into the rectum and press out its content, while lying on your side. Apply one suppository 2 times a day for one month. Extend your course of treatment up to 90 days, if necessary.
No side effects found.
No product dependence and no rebound syndrome.
Do not use during pregnancy.
No other contraindications detected.
Keep the product in a dark cool place at the temperature below 25°С.
Shelf life is 3 years from the date of production.
Do not use the product after expiration of the date of production, specified on the package.
SCHALI® Care Personal Hygiene Products are made under license No. 286-S.